This article contains content that is written like an advertisement. (March 2017) |
Company type | Public |
---|---|
ISIN | INE030A01027 |
Industry | Consumer goods |
Predecessor | Indian Vanaspati Manufacturing Company (1931–1956) Lever Brothers India Limited (1933–1956) United Traders Limited (1935–1956) Hindustan Lever Limited (1956–2007) |
Founded | 1933 |
Headquarters | , India |
Key people | Rohit Jawa (CEO)[1] |
Products | |
Revenue | ₹61,092 crore (US$7.7 billion) (2023)[2] |
₹13,409 crore (US$1.7 billion) (2023)[2] | |
₹10,143 crore (US$1.3 billion) (2023)[2] | |
Total assets | ₹73,087 crore (US$9.2 billion) (2023)[2] |
Total equity | ₹50,522 crore (US$6.3 billion) (2023)[2] |
Number of employees | 21,000 (2020)[2] |
Parent | Unilever plc (61.90%) |
Website | www |
Hindustan Unilever Limited (HUL) is a British-owned Indian final good company headquartered in Mumbai.[3] It is a subsidiary of the British company Unilever. Its products include foods, beverages, cleaning agents, personal care products, water purifiers and other fast-moving consumer goods (FMCGs).
HUL was established in 1931 as Hindustan Vanaspati Manufacturing Co. Following a merger of constituent groups in 1956, it was renamed Hindustan Lever Limited. The company was renamed again in June 2007 as Hindustan Unilever Limited.[4]
Hindustan Unilever has been at the helm of a lot of controversies, such as dumping highly toxic mercury-contaminated waste in regular dumps, contaminating the land and water of Kodaikanal. (See: Kodaikanal mercury poisoning). The British company also faced major flak for an advertising campaign attacking the Hindu pilgrimage site at Kumbh Mela, calling it a "place where old people get abandoned,"[5][6] a move that was termed racist and insensitive.[5]
As of 2019, Hindustan Unilever's portfolio had more than 50 product brands in 14 categories. The company has 21,000 employees and recorded sales of ₹34,619 crores in FY2017–18.[3]
In December 2018, HUL announced its acquisition of GlaxoSmithKline India's consumer business for US$3.8 billion in an all equity merger deal with a 1:4.39 ratio.[7][8] However the integration of GSK's 3,800 employees remained uncertain as HUL stated there was no clause for retention of employees in the deal.[8] In April 2020, HUL completed its merger with GlaxoSmithKline Consumer Healthcare (GSKCH India) after completing all legal procedures.[9] In December 2022, HUL's market cap was Rs. 638548.42 crore.[10]